The World Health Organization's technical advisory group requested "further clarifications" from Bharat Biotech for its COVID-19 vaccine ‘Covaxin’ on Tuesday in order to complete a final risk-benefit analysis for the vaccine's Emergency Use Listing. For a final review, the technical advisory panel will convene on November 3rd. On Tuesday, the technical advisory panel convened